Genedrive HCV ID Kit

Add to wishlist

A simple, highly accurate, WHO pre-qualified qualitative point-of-need molecular diagnostics solution testing for confirmation of active HCV infection in 90 min

Genedrive HCV ID Kit

Decentralised Diagnostics to Support the New Era of HCV Treatment

Traditional diagnostic algorithms are complex and time consuming. However, with new simplified World Health Organisation (WHO) HCV guidelines1 and the introduction of new effective Direct Acting Antiviral Agents (DAAs), there is now a greater emphasis on increasing access to diagnostic if countries are to meet the WHO 2030 Hepatitis C elimination targets.2

Genedrive HCV ID kit – Direct from plasma (without the need for viral RNA extraction) with results in 90 mins, facilitating faster treatment decisions and improving linkage to care.Complete the test, provide a confirmatory result and initiate patient treatment all in one visit, using a test and treat strategy.

  • Qualitative HCV RNA test ideal for point-of-need settings
  • 99.8% sensitivity and 100% specificity3
  • Results direct from plasma
  • Sample to results in 90 mins
  • Single-use consumables

Reference

  1. Guidelines for the care and treatment of persons diagnosed with chronic HCV infection, Updated version, July 2018. Geneva: WHO 2018.
  2. WHO, Global hepatitis report, 2017
  3. Llibre A, Shimakawa Y, Mottez E, Ainsworth S, Buivan T, Firth R et al. Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus. BMJ Gut 2018; : 1–8.
Product Name Genedrive HCV ID Kit
Product Code ZPS 31000
Technology PCR with post-amplification melt curve analysis
Target HCV Genotypes 1a, 1b, 2, 3, 4, 5 and 6
Sample Type Fresh human whole blood derived plasma in K2 or K3 EDTA anticoagulant
Sample Volume 30 µL plasma
RNA Extraction Not required
Time to Result 90 minutes
Hands on Time under 5 minutes
In Built Control Internal Control
Pack Size 10 tests/ Kit
Storage Condition 2 – 30 °C
Compatible Platform Genedrive System
+ Features & Benefits
  • Qualitative HCV RNA test ideal for point-of-need settings
  • 99.8% sensitivity and 100% specificity3
  • Results direct from plasma
  • Sample to results in 90 mins
  • Single-use consumables

Reference

  1. Guidelines for the care and treatment of persons diagnosed with chronic HCV infection, Updated version, July 2018. Geneva: WHO 2018.
  2. WHO, Global hepatitis report, 2017
  3. Llibre A, Shimakawa Y, Mottez E, Ainsworth S, Buivan T, Firth R et al. Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus. BMJ Gut 2018; : 1–8.
+ Specifications
Product Name Genedrive HCV ID Kit
Product Code ZPS 31000
Technology PCR with post-amplification melt curve analysis
Target HCV Genotypes 1a, 1b, 2, 3, 4, 5 and 6
Sample Type Fresh human whole blood derived plasma in K2 or K3 EDTA anticoagulant
Sample Volume 30 µL plasma
RNA Extraction Not required
Time to Result 90 minutes
Hands on Time under 5 minutes
In Built Control Internal Control
Pack Size 10 tests/ Kit
Storage Condition 2 – 30 °C
Compatible Platform Genedrive System